M. De Smet

Safety, Tolerability, and Pharmacokinetics of Raltegravir After Single and Multiple Doses in Healthy Subjects

Marian Iwamoto, LA Wenning, AS Petry et al. · Clinical Pharmacology & Therapeutics · 2007 · 170 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

V. Cocquyt, Simon Van Belle, Robert Reinhardt et al. · European Journal of Cancer · 2001 · 148 citations

Medicine, Pharmacology, Pharmacotherapy +5

Heavy Metals Bioremediation of Soil

Ludo Diels, M. De Smet, L. Hooyberghs et al. · Molecular Biotechnology · 1999 · 123 citations

Engineering, Environmental Sciences, Soil Sciences +12

Pharmacodynamic and pharmacokinetic effects of MK-0343, a GABA _A α _2,3 subtype selective agonist, compared to lorazepam and placebo in healthy male volunteers

Sanne Lysbet de Haas, Saco J. de Visser, J. P. Van Der Post et al. · Journal of Psychopharmacology · 2007 · 105 citations

Medicine, Pharmacology, Pharmacotherapy +17

Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects

Rajesh Krishna, AJ Bergman, Bo Jin et al. · Clinical Pharmacology & Therapeutics · 2008 · 100 citations

Life Sciences, Pharmacokinetics, Pharmacology +16